Merge Bio Therapeutics Corp

CIK 2086124 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Merge Bio Therapeutics Corp.

Recent SEC filings

FiledFormAccession number
Sep 17, 2025D0001231919-25-000205